Effect of SP3 silencing on cytokeratin expression pattern in HPV-positive cells

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 1, 2009, Pages 163-168

  Lucchese, A ^a,b   Serpico, R ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE   (Italy)

Author keywords

Ck18; Ck19; Cytokeratin pattern; Sp3 silencing; Squamous cell cancer

Indexed keywords

CYTOKERATIN; CYTOKERATIN 10; CYTOKERATIN 13; CYTOKERATIN 17; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN 4; CYTOKERATIN 6; CYTOKERATIN 7; CYTOKERATIN 8; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SP3;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; WART VIRUS;

EID: 62649167961     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200118     Document Type: Article

References (32)

1. Suske G. The Sp-family of transcription factors. Gene 1999; 238:291-300.
2. Udvadia AJ, Templeton DJ, Horowitz JM. Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proc Natl Acad Sci USA 1995; 92:3953-7.
3. Apt D, Watts RM, Suske G, Bernard HU. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology 1996; 224:281-91.
4. Lou Z, Maher VM, McCormick JJ. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein. Gene 2005; 351:51-9.
5. Lou Z, O'Reilly S, Liang H, Maher VM, Sleight SD, McCormick JJ. Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation. Cancer Res 2005; 65:1007-17.
6. Tuthill MC, Wada RK, Arimoto, JM, Sugino CN, Kanemaru KK, Takeuchi KK, Sidell N. N-myc oncogene expression in neuroblastoma is driven by Sp1 and Sp3. Mol Genet Metab 2003; 80:272-80.
7. Kumar AP, Butler AP. Enhanced Sp1 DNA-binding activity in murine keratinocyte cell lines and epidermal tumors. Cancer Lett 1999; 137:159-65.
8. Sinha S, Fuchs E. Identification and dissection of an enhancer controlling epithelial gene expression in skin. Proc Natl Acad Sci USA 2001; 98:2455-60.
9. Doorbar J, Ely S, Sterling J, McLean C, Crawford L. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature 1991; 352: 824-7.
10. Brembeck FH, Rustgi AK. The tissue-dependent keratin 19 gene transcription is regulated by GKLF/KLF4 and Sp1. J Biol Chem 2000; 275:28230-9.
11. Moles JP, Schiller JT, Tesniere A, Leigh IM, Guilhou JJ, Basset-Seguin N. Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression. J Cell Sci 1994; 107:435-41.
12. Rosini S, Zappacosta R, Di Bonaventura G, Caraceni D, Pilla D, Di Girolamo G, Esposito A, Orsini T, Setta S, Vizzino M, Piccolomini M, Piccolomini R. Management and triage of women with human papillomavirus infection in follow-up for low-grade cervical disease: association of HPV-DNA and RNA- based methods. Int J Immunopathol Pharmacol 2007; 20:341-7.
13. Kanduc D. Translational regulation of human papillomavirus type 16 E7 mRNA by the peptide SEQIKA, shared by rabbit alpha(1)-globin and human cytokeratin 7. J Virol 2002; 76:7040-8.
14. Favia G, Kanduc D, Lo Muzio L, Lucchese A, Serpico R. Possible association between HPV16 E7 protein level and cytokeratin 19. Int J Cancer 2004; 111:795-7.
15. Kozuka T, Aoki Y, Nakagawa K, Ohtomo K, Yoshikawa H, Matsumoto K, Yoshiike K, Kanda T. Enhancer-promoter activity of human papillomavirus type 16 long control regions isolated from cell lines SiHa and CaSki and cervical cancer biopsies. Jpn J Cancer Res 2000; 91:271-9.
16. Pisani S, Imperi M, Seganti L, Superti F, Tinari A, Bucci M, Degener AM. Effect of HSV-2 infection on the expression of HPV 16 genes in CaSki cells. Int J Immunopathol Pharmacol 2004; 17:65-70.
17. Sun TT, Eichner R, Nelson WG, Tseng SC, Weiss RA, Jarvinen M, Woodcock-Mitchell J. Keratin classes: molecular markers for different types of epithelial differentiation. J Invest Dermatol 1983; 81:109-15.
18. Schermer A, Jester JV, Hardy C, Milano D, Sun TT. Transient synthesis of K6 and K16 keratins in regenerating rabbit corneal epithelium: keratin markers for an alternative pathway of keratinocyte differentiation. Differentiation 1989; 42:103-10.
19. O'Guin WM, Galvin S, Schermer A, Sun TT. Patterns of keratin expression define distinct pathways of epithelial development and differentiation. Curr Top Dev Bio 1987; 22:97-125.
20. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms Histopathology 2002; 40:403-39.
21. Reichelt J, Furstenberger G, Magin TM. Loss of keratin 10 leads to mitogen-activated protein kinase (MAPK) activation, increased keratinocyte turnover, and decreased tumor formation in mice. J Invest Dermatol 2004; 123:973-81.
22. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: pattern of expression in normal epithelia, tumor and culture cells. Cell 1982; 31:11-24.
23. Lane EB, Alexander CM. Use of keratin antibodies in tumor diagnosis. Semin Cancer Biol 1990; 1:165-79.
24. Carrilho C, Alberto M, Buane L, David L. Keratins 8, 10, 13, and 17 are useful markers in the diagnosis of human cervix carcinomas. Hum Pathol 2004; 35: 546-51.
25. Ramaekers F, van Niekerk C, Poels L, Schaafsma E, Huijsmans A, Robben H, Schaart G, Vooijs P. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 1990; 36:641-55.
26. de Araujo VC, de Sousa SO, Carvalho YR, de Araujo NS. Application of immunohistochemistry to the diagnosis of salivary gland tumours. Appl Immunohistochem Molecul Morphol 2000; 8:195-202.
27. Al-Awadhi R, Van Noorden S, Coleman DV. Evaluation of NMP179 for the detection of squamous intraepithelial neoplasia in ThinPrep cervical slides using a combination of double immunostaining and morphometric methods of analysis. Diagn Cytopathol 2004; 31:135-40.
28. Raul U, Sawant S, Dange P, Kalraiya R, Ingle A, Vaidya M. Implications of cytokeratin 8/18 filament formation in stratified epithelial cells: induction of transformed phenotype. Int J Cancer 2004; 111:662-8.
29. Gilbert S, Loranger A, Daigle N, Marceau N. Simple epithelium keratins 8 and 18 provide resistance to Fas-mediated apoptosis. The protection occurs through a receptor-targeting modulation. J Cell Biol 2001; 154:763-73.
30. Ku NO, Soetikno RM, Omary MB. Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury. Hepatology 2003; 37:1006-14.
31. Bonfrer JM, Gaarenstroom KN, Kenter GG, Korse CM, Hart AA, Gallee MP, Helmerhorst TJ, Kenemans P. Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer. Gynecol Oncol 1994; 55:371-5.
32. Nie M, Li B, Zeng G, He Z, Chen Q, Zhou M, Luo G, Zeng X. Changes of simple epithelial cytokeratin during oral carcinogenesis. Hua Xi Kou Qiang Yi Xue Za Zhi 1999; 17:208-20.